In a comprehensive Genomic Press Interview published today, Dr. Stephen Ross, a leading figure in psychedelic medicine at New ...

Wellness startups could be revolutionizing healthcare by offering cheaper, faster alternatives to traditional doctors and ...

The U.S. Food and Drug Administration (FDA) granted platform technology designation to the viral vector used in SRP-9003, an ...

LMNA-related dilated cardiomyopathy (LMNA DCM) is one of the most aggressive forms of DCM, affecting approximately 100,000 individuals in the United States and Europe, who progress rapidly to ...

Researchers at the University of Pennsylvania believe they’re one step closer to finding a treatment that fights glioblastoma ...

YolTech has received FDA approval for its investigational new drug (IND) application for YOLT-101 to treat HeFH.